Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and clinical efficacy of VM202RY injected
via transendocardial route using C-Cathez® catheter (Celyad, S.A., Belgium) in subjects with
AMI.
- Stage 1: Evaluation of safety and tolerability of VM202RY injection
- Stage 2: Evaluation of safety and efficacy of VM202RY injection